• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Genzyme

Genzyme

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. FDA Grants Fast Track Designation to Genzyme ’s Investigational Substrate Reduction Therapy for the Treatment of Fabry Disease

    FDA Grants Fast Track Designation to Genzyme ’s Investigational Substrate Reduction Therapy for the Treatment of Fabry Disease

  2. Research and Markets: Global Gaucher Disease Market 2015-2019: Key Players Include Actelion Pharmaceuticals, Genzyme , Pfizer & Shire

    Research and Markets: Global Gaucher Disease Market 2015-2019: Key Players Include Actelion Pharmaceuticals, Genzyme , Pfizer & Shire

  3. REITs, Target Dates, Dollar-Proofing, and More

    A roundup of investment news.

  4. High-Confidence Stock Picks

    Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.

  5. Early Favorites for Manager of the Year--Domestic Stock

    Who's in front heading 'round the bend?

  6. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

  7. Back to Basics

    This screen finds stocks that would make it into Morningstar's Wide-Moat Focus strategy.

  8. Funds Betting on Apple, Google, and RIM

    Many funds' fortunes have turned amid these stocks' volatility.

  9. Tech Stock Rally Leaves Some Funds Behind

    Plus, Vanguard says 401(k) investors stayed the course in 2008, Macquarie Group buys Delaware Investments, more leveraged ETF warnings, and more.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.